ReviewPharmaceuticals (Basel, Switzerland)2021

Current Status of Baricitinib as a Repurposed Therapy for COVID-19.

Maha Saber-Ayad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.